Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01722630
Other study ID # FRF-2012-DH
Secondary ID
Status Completed
Phase N/A
First received November 2, 2012
Last updated November 5, 2012
Start date March 2012
Est. completion date October 2012

Study information

Verified date November 2012
Source Catholic University of the Sacred Heart
Contact n/a
Is FDA regulated No
Health authority Italy: Ethics CommitteeItaly: Ministry of Health
Study type Interventional

Clinical Trial Summary

Aim of this study was to investigate the cardiac and renal responses to the administration of different amount of crystalloids, with and without dopamine, during gynaecological laparoscopic surgery.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date October 2012
Est. primary completion date July 2012
Accepts healthy volunteers No
Gender Female
Age group 24 Years to 42 Years
Eligibility Inclusion Criteria:

- ASA I

- age 24-42

- patients undergoing gynaecological laparoscopy

Exclusion Criteria:

- cardiovascular diseases

- renal and endocrine disorders

- obesity (BMI > 30 Kg/m2)

- the assumption of drugs that could interfere with renal parameters considered in the study

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Dopamine


Locations

Country Name City State
Italy Catholic University of the sacred Heart Rome

Sponsors (1)

Lead Sponsor Collaborator
Catholic University of the Sacred Heart

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary estimated glomerular filtration rate, tissue Doppler imaging, E/Ea EGFr, tissue Doppler imaging and E/Ea are registered after the induction of pneumoperitoneum and Trendelemburg position, and compared to those registered before the induction of anesthesia. patients will be followed for the duration of surgery, an expected average of 3 hours No
Secondary total intra operative diuresis (TID) TID will be measured at the end of surgery patients will be followed for the duration of surgery, an expected average of 3 hours No